During the past decade, Mercy Hospital Washington conducted 118 clinical trials. In the 10-year time frame, 118 clinical trials started and 22 clinical trials were completed, i.e. on average, 18.6% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 19 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Hospital Washington" #1 sponsor was "National Cancer Institute (NCI)" with 55 trials, followed by "Alliance for Clinical Trials in Oncology" with 24 trials sponsored, "SWOG Cancer Research Network" with 20 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored and "Wake Forest University Health Sciences" with 15 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Hospital Washington" #1 collaborator was "National Cancer Institute (NCI)" with 68 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Hospital Washington" are "Stage IV Lung Cancer AJCC v8" (9 trials), "Invasive Breast Carcinoma" (7 trials), "Metastatic Malignant Neoplasm in the Brain" (6 trials), "Recurrent Lung Non-Small Cell Carcinoma" (6 trials) and "Clinical Stage IV Cutaneous Melanoma AJCC v8" (5 trials). Many other conditions were trialed in "Mercy Hospital Washington" in a lesser frequency.

Most popular intervention types in "Mercy Hospital Washington" are "Drug" (94 trials), "Other" (66 trials), "Biological" (51 trials), "Procedure" (41 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (27 trials), "Quality-of-Life Assessment" (26 trials), "Questionnaire Administration" (23 trials), "Computed Tomography" (21 trials) and "Laboratory Biomarker Analysis" (20 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Hospital Washington" are 111 trials for "All" genders, 13 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy Hospital Washington". undefined are not yet recruiting, 57 are recruiting, 48 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Mercy Hospital Washington, 6 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Hospital Washington, 4 "Phase 1" clinical trials were conducted, 67 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".